Alopecia areata update - 05/09/11
Abstract |
Alopecia areata (AA) is a nonscarring hair loss condition. Among the many factors under investigation in the pathogenesis of AA, the main areas of concentration have been genetic constitution as well as nonspecific immune and organ-specific autoimmune reactions. Treatment with intralesional corticosteroid injections for localized patchy AA and topical immunotherapy for extensive AA have proven successful in the majority of patients, although all treatments are palliative and do not change the prognosis of the disease. (J Am Acad Dermatol 2000;42:549-66.) Learning Objective: At the conclusion of this learning activity, participants should be familiar with the latest information on etiology, clinical features, diagnosis, histopathology, and state-of-the-art treatment of alopecia areata.
Le texte complet de cet article est disponible en PDF.Plan
Reprint requests: Jerry Shapiro, MD, FRCPC, 835 W 10th Ave, Vancouver, British Columbia V5Z 4E8. E-mail: shapiro@interchg.ubc.ca . |
|
*Dr Madani was Hair Fellow, University of British Columbia Hair Research and Treatment Center during the work for this article. |
Vol 42 - N° 4
P. 549-566 - avril 2000 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?